Next Article in Journal
HIV and SARS-CoV-2 Pathogenesis and Vaccine Development
Previous Article in Journal
Simultaneous Production of a Virus-Like Particle Linked to dsRNA to Enhance dsRNA Delivery for Yellow Head Virus Inhibition
 
 
Article
Peer-Review Record

Impact of Dextran-Sodium-Sulfate-Induced Enteritis on Murine Cytomegalovirus Reactivation

Viruses 2022, 14(12), 2595; https://doi.org/10.3390/v14122595
by Alexandre Jentzer 1,†, Sébastien Fauteux-Daniel 2, Paul Verhoeven 1,3, Aymeric Cantais 1, Melyssa Yaugel Novoa 1, Fabienne Jospin 1, Blandine Chanut 1, Nicolas Rochereau 1, Thomas Bourlet 1,3, Xavier Roblin 1,4, Bruno Pozzetto 1,3 and Sylvie Pillet 1,3,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Viruses 2022, 14(12), 2595; https://doi.org/10.3390/v14122595
Submission received: 18 October 2022 / Revised: 11 November 2022 / Accepted: 18 November 2022 / Published: 22 November 2022
(This article belongs to the Section Animal Viruses)

Round 1

Reviewer 1 Report

Clinical study results have reported that CMV infection (reactivation) contributes to refractory ulcerative colitis. Results from mouse models support this association.

In this study, DSS was administered to MCMV-infected BALB/c mice, and the effect of its reactivation on intestinal inflammation was examined.

Acute intestinal inflammation induced by DSS administration did not reactivate MCMV in colonic tissue. As a result, the presence or absence of infection did not contribute to the exacerbation of intestinal inflammation.

As the authors know well, DSS acute colitis is unsuitable for a UC model. Therefore, the effect of this CMV reactivation on the pathogenesis of UC should be examined in a chronic colitis model.

Author Response

Clinical study results have reported that CMV infection (reactivation) contributes to refractory ulcerative colitis. Results from mouse models support this association.

In this study, DSS was administered to MCMV-infected BALB/c mice, and the effect of its reactivation on intestinal inflammation was examined.

Acute intestinal inflammation induced by DSS administration did not reactivate MCMV in colonic tissue. As a result, the presence or absence of infection did not contribute to the exacerbation of intestinal inflammation.

As the authors know well, DSS acute colitis is unsuitable for a UC model. Therefore, the effect of this CMV reactivation on the pathogenesis of UC should be examined in a chronic colitis model.

As rightly said, DSS acute colitis is unsuitable for a chronic colitis model.

As mentioned in the introduction, the gut inflammation was induced by the oral administration of dextran sodium sulfate (DSS) that acts as a trigger of acute enteritis.

Chronic colitis model such as TCR-α deficient mice induce significant immune deficiency which is not representative of the level of immunosuppression of patients with UC. We have modified several sentences in order to insist on the acute colitis: lines  63, and 331-333

Reviewer 2 Report

This manuscript focusses on an important topic, which will doubtless be of interest to readers. The attempt to extend useful animal models for cytomegalovirus disease is a worthy research goal and the decision to publish negative results is laudable.

The paper is well put together. There are some mistakes in the English that would benefit from the attention of a native speaker, but it is in general understandable. The figures are clearly made and clearly explained and show what is described.

There are only a few issues, one major, which I would like to see addressed in this otherwise very good publication.

Results:

Section 3.2 line 207. “the measure of the 0” appears to be a mistake.

Figure 3: The title of this figure is not informative.

Figure 4: This experiment is central to the conclusions of the paper and does not include a positive control. DSS induced reactivation is not seen by IHC for IE1, however no positive control for reactivation or even for IE1 expression is included. This seriously undermines the paper and should be addressed, particularly, as is mentioned in the discussion, as these results contradict those of other groups. I appreciate that repeating the entire experiment is probably not possible; would it however be feasible to reanalyse these gut samples in parallel with others where IE1 is expressed simply to show that the staining is working? Some effort to address this point should be made.

Conclusions: The final sentence has been left in the manuscript, presumably unintentionally.

Comments for author File: Comments.pdf

Author Response

This manuscript focusses on an important topic, which will doubtless be of interest to readers. The attempt to extend useful animal models for cytomegalovirus disease is a worthy research goal and the decision to publish negative results is laudable.

Thank you very much

The paper is well put together. There are some mistakes in the English that would benefit from the attention of a native speaker, but it is in general understandable. The figures are clearly made and clearly explained and show what is described.

The english language has been reviewed especially by SFD, a canadian native researcher

There are only a few issues, one major, which I would like to see addressed in this otherwise very good publication.

Thank you very much

Results:

Section 3.2 line 207. “the measure of the 0” appears to be a mistake.

The sentence has been modified by “After administration of DSS at D30 in groups 2 and 4, BALB/c mice were monitored daily by measure the weight loss, stool consistency and faecal blood.” Line 210

Figure 3: The title of this figure is not informative. 

The tittle has been changed by: “Monitoring of weight loss, clinical score and gut inflammation during the experiment”. Lines 216-217

Figure 4: This experiment is central to the conclusions of the paper and does not include a positive control. DSS induced reactivation is not seen by IHC for IE1, however no positive control for reactivation or even for IE1 expression is included. This seriously undermines the paper and should be addressed, particularly, as is mentioned in the discussion, as these results contradict those of other groups. I appreciate that repeating the entire experiment is probably not possible; would it however be feasible to reanalyse these gut samples in parallel with others where IE1 is expressed simply to show that the staining is working? Some effort to address this point should be made.

 

We totally agree with your comment. A positive control of IHC experimentation should be added. In order to prove that IE1 labelling can reveal CMV infection we propose to add a supplementary figure (in Methods: 2.7. Immunohistochemistry) with positive MCMV labelling of mouse salivary gland. We know that it is not the same tissue but MCMV administered by intraperitoneal (IP) is replicative at D21 in the salivary glands. It is therefore probably the best positive control for our model.

Conclusions: The final sentence has been left in the manuscript, presumably unintentionally.

Indeed, it was a mistake, thank you for your vigilance: the sentence has been deleted.

Round 2

Reviewer 1 Report

none 

Reviewer 2 Report

Thank you very much for making the suggested changes.

Back to TopTop